|Bid||7.52 x 0|
|Ask||7.68 x 0|
|Day's range||6.98 - 7.86|
|52-week range||1.50 - 16.64|
|Beta (5Y monthly)||1.37|
|PE ratio (TTM)||N/A|
|Earnings date||17 Sep 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||26.65|
Shell pulls out of joint venture to build UK sustainable jet fuels plantWithdrawal a blow to Boris Johnson’s desire for UK to achieve first zero-emission long-haul flight
Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced today an agreement with CarePICS, the latest resource addition to Fuse’s comprehensive portfolio and biologics product offerings for wound care.
Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company"), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the initial launch of FuseChoiceTM and FuseChoiceTM Plus Amniotic & Umbilical Membranes, and FuseChoiceTM Plus Amniotic Joint Cushioning Fluid, the latest additions to a comprehensive line of biologics product offerings.